Portfolio company Qkine secured 1.5 million pounds of investment.
Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications
Qkine manufactures high-quality and novel growth factors, supporting scientists in developing and scaling stem cell, organoid, cellular agriculture and regenerative medicine applications. We are also developing new growth factor technologies to enable emerging fields such as cultured meat and 3D cell culture.